Safety of and Immune Response to a DNA HIV Vaccine (VRC-HIVDNA009-00-VP) in HIV Infected Individuals With Acute HIV Infection
Clinical trial NCT00125099 · COMPLETED
Trial details
- NCT number
- NCT00125099
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.